Zoetis

Zoetis

Yahoo Finance • 2 days ago

1 healthcare stock with impressive fundamentals and 2 we ignore

1 healthcare stock with impressive fundamentals and 2 we ignore Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stock... Full story

Yahoo Finance • 13 days ago

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today... Full story

Yahoo Finance • 14 days ago

IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?

Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics - US's Substack. In this article, we will summarize the bulls' thesis on IDXX. IDEXX Laboratories, Inc.'s share was trading at $553.4... Full story

Yahoo Finance • 16 days ago

Apple downgraded, Akamai upgraded: Wall Street's top analyst calls

Apple downgraded, Akamai upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by... Full story

Yahoo Finance • 16 days ago

Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX

Investing.com -- Jefferies downgraded Zoetis and Elanco to Hold from Buy on Tuesday, warning that pricing power in animal health is at risk. The firm reiterated its Buy rating on IDEXX Laboratories. Still guessing which stocks will beat t... Full story

Yahoo Finance • 21 days ago

Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug

Middle Coast Investing, an investment advisor firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Market breadth in Q3 2026 reviews shows dominance by a few sectors, with S&P 500 stocks averaging a 9.... Full story

Yahoo Finance • 21 days ago

3 Reasons ZTS is Risky and 1 Stock to Buy Instead

3 Reasons ZTS is Risky and 1 Stock to Buy Instead Zoetis has gotten torched over the last six months - since April 2026, its stock price has dropped 37.6% to $75.34 per share. This was partly due to its softer quarterly results and may ha... Full story

Yahoo Finance • 25 days ago

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 28 days ago

Zoetis (ZTS) Says Study Shows Simparica Trio Outperformed A Rival On Resistant Heartworm

Zoetis (NYSE:ZTS) reported new peer-reviewed data on its Simparica Trio product comparing protection against resistant heartworm to NexGard Plus. The publication focuses on a resistant heartworm strain that has become a growing concern for... Full story

Yahoo Finance • 29 days ago

These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks

It's going to be a very long road back to all-time stock price highs for some well-known companies battling through challenging industry conditions and management missteps. Seven S&P 500 (^GSPC) stocks with market caps above $20 billion n... Full story

Yahoo Finance • 30 days ago

S&P 500 hits a record; These $20B stocks still need 200% to break even

[Abstract Data Chart] The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) tagged a fresh intraday record high on Tuesday morning, extending a bull market that began in October 2022. The milestone masks a sharp split inside the in... Full story

Yahoo Finance • 30 days ago

Burry flags six stocks as likely tax-loss sale candidates

Astrid Stawiarz Michael Burry outlined how he is positioning his portfolio for the fourth-quarter tax-loss harvesting season, highlighting six stocks that stand out as likely tax loss sale candidates that may not do well over the next cou... Full story

Yahoo Finance • last month

Vertex (VRTX) or Regeneron (REGN)? Two Biotech Moats, Two Very Different Bets

Biotech companies are strange businesses to think about in terms of competitive advantages. A software company can lock customers into an ecosystem for years. A manufacturer can have a cost advantage. A biotech company, meanwhile, can spen... Full story

Yahoo Finance • last month

Unpacking Q2 Earnings: Merck (NYSE:MRK) In The Context Of Other Branded Pharmaceuticals Stocks

Unpacking Q2 Earnings: Merck (NYSE:MRK) In The Context Of Other Branded Pharmaceuticals Stocks Looking back on branded pharmaceuticals stocks' Q2 earnings, we examine this quarter's best and worst performers, including Merck (NYSE:MRK) an... Full story

Yahoo Finance • 2 months ago

Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note

In the latest close session, Zoetis (ZTS) was down 2.22% at $71.40. This change lagged the S&P 500's 0.17% gain on the day. Elsewhere, the Dow saw a downswing of 0.18%, while the tech-heavy Nasdaq appreciated by 0.4%. The animal health co... Full story

Yahoo Finance • 2 months ago

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?

Photo by Pexels on Pixabay If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying repl... Full story

Yahoo Finance • 2 months ago

Michael Burry pulls back on risk, sheds December 2026 Nvidia and Palantir puts amid portfolio-wide cuts

[Financial Analyst Working on a Computer with Multi-Monitor Workstation with Real-Time Stocks, Commodities and Exchange Market Charts. Businessman Works in Investment Bank Downtown Office at Night.] gorodenkoff Michael Burry of 'The Big S... Full story

Yahoo Finance • 2 months ago

Zoetis (ZTS) Shares Drop After Earnings Revision

Impax Asset Management, based in London and specializing in sustainable investing, released its Q2 2026 investor letter for the "Impax US Sustainable Economy Fund". The letter can be downloaded here. The US Sustainable Economy portfolio ou... Full story

Yahoo Finance • 2 months ago

Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030

Company Logo 249-Page Report Delivers Country-by-Country Forecasts Across 15 Markets, Competitive Profiles of 32 Companies, and the Investment-Grade Data You Need to Act With Confidence Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Vet... Full story

Yahoo Finance • 2 months ago

Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

PARSIPPANY, N.J., September 02, 2026--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, and Jay Saccaro, EVP, Chief Financial Officer and Chief Operating Officer, will participate in a fire... Full story